Latest News about Biotech
Recent news which mentions Biotech
From Benzinga
From Benzinga
Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars
April 17, 2025
From Benzinga
From Benzinga
Trump Administration Opens Probe Into Foreign Drug Imports, Eyes Tariffs Under National Security Law
April 16, 2025
Tickers
NEWS
From Benzinga
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
April 16, 2025
From Benzinga
Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients
April 16, 2025
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study
April 16, 2025
From Benzinga
Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts
April 15, 2025
From Benzinga
From Benzinga
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
April 15, 2025
From Benzinga
From Benzinga
Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide Delivery
April 15, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free